Skip to main content
. 2019 Jan 17;2019:4652596. doi: 10.1155/2019/4652596

Figure 10.

Figure 10

Effect of DC-IL10 on the TGF-β/smad signaling pathway. DC-IL10 treatment significantly decreased the expression of TGF-β1, α-SMA, smad2, and smad3 and increased the smad7 expression than the model group and DC-mock treatment group (p < 0.05 for all). Data are normalized to GAPDH protein expression levels. Data represent mean ± SD of 8 mice in each group. GAPDH: glyceraldehyde 3-phosphate dehydrogenase. G1: control group (n = 8); G2: model group (n = 8); G3: DC-mock-treated group (n = 8); G4: DC-IL10-treated group (n = 8).